A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors

NCT07068932 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Tumors of Adults

Interventions

DRUG: SHR-4506 Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.